PHGE — Biomx Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- $11.71m
- -$14.07m
- 29
- 52
- 20
- 24
Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.001 | 0.347 | -30.1 | -36.2 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | — | -0.881 | 3.01 | 2.98 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.001 | 0.33 | 0.453 | 3.1 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -0 | -0.205 | -24.4 | -27.6 |
| Capital Expenditures | — | — | -1.01 | -3.68 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | -70 | -9.85 | 19.9 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | — | -70 | -10.9 | 16.2 |
| Financing Cash Flow Items | -0.025 | 0.241 | -0.075 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0 | 70.9 | 0.134 | 37.3 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 0.696 | -35.2 | 25.9 |